Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
about
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapyWhich is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions.Platelet function tests: a comparative review.Inflammatory and antioxidant pattern unbalance in "clopidogrel-resistant" patients during acute coronary syndromeMonitoring the effectiveness of antiplatelet therapy: opportunities and limitations.Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?Advances in the monitoring of anti-P2Y12 therapy.Antiplatelets in acute coronary syndrome: personal perspectives.Gender and anti-thrombotic therapy: from biology to clinical implications.Platelet function testing in cardiac surgery.The concordance and correlation of measurements by multiple electrode and light transmittance aggregometries based on the pre-defined cutoffs of high and low on-treatment platelet reactivity.Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.Comparison of venous and arterial blood sampling for the assessment of platelet aggregation with whole blood impedance aggregometry.Defining predictive values using three different platelet function tests for CYP2C19 phenotype status on maintenance dual antiplatelet therapy after PCI.Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser.Sequential ADP-stimulated light transmission and multiple electrode aggregometry in patients taking aspirin and clopidogrel after non ST-elevation myocardial infarction.Don't forget cardioprotective strategies in high-risk surgical patients!Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery.Monitoring ASA and P2Y12-specific platelet inhibition--comparison of conventional (single) and multiple electrode aggregometry.Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial.Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosisPhenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study
P2860
Q33791290-84B7B594-D2CA-49E3-BB15-F31188176903Q34224240-A3B7AFB4-33C4-47ED-9567-C2255B592D70Q35121464-8860D96B-A0F6-43EC-B026-69DF9F519562Q35250401-D2A7281E-69E8-45BC-ACC5-6E295EAFAA64Q35373683-104F08B4-3B7C-4FCA-916D-42895EF4EF0BQ37497555-94593D8C-DA72-4E2B-8AFA-98AC893C8BBAQ37973457-CD86F698-8C9E-4055-8A51-EC99E05C349EQ38037121-A8C0128C-D221-4F90-9FB8-2417369ED381Q38068595-F5C7D74A-CD89-4C95-BA4B-C4AC58E757F8Q38182428-A8B7FD2B-590E-4171-A960-9BF92F3DDE7CQ38930441-1C569C38-6F92-4F1D-86CC-6E24A02172B4Q39704629-EC67F725-7F00-411D-B892-0FB53BDDCDABQ41574497-13CF7723-31D0-4890-B9D2-EF39482881CBQ43515622-17B9F10D-CD01-417C-86CE-546123D8BA20Q43710350-3F1D3D84-C00D-4D6A-9587-52405B3294FEQ44664771-951C5989-0A38-4478-BBA8-ECF8C50FAC34Q45381763-E7F84386-F6A0-4F0E-830B-912296451680Q48171017-981F9AF9-6203-49B9-BD37-0AEEE1DC8002Q50994122-00D7DD5F-B43C-4604-8A4A-440330C7E142Q53420606-8EC60219-D69B-4BB9-8DFD-5D608AC12CB7Q54335457-58FFBBDE-FA86-46AD-9D08-3E5EFC1A7893Q57734957-7EC91532-87E9-41DD-9F2A-2015AE0BCBDAQ58071120-BBE70377-5BAE-43E2-8D05-9F4A5C406E44
P2860
Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Comparison of methods for moni ...... e blood in high-risk patients.
@en
Comparison of methods for moni ...... e blood in high-risk patients.
@nl
type
label
Comparison of methods for moni ...... e blood in high-risk patients.
@en
Comparison of methods for moni ...... e blood in high-risk patients.
@nl
prefLabel
Comparison of methods for moni ...... e blood in high-risk patients.
@en
Comparison of methods for moni ...... e blood in high-risk patients.
@nl
P2093
P50
P356
P1476
Comparison of methods for moni ...... e blood in high-risk patients.
@en
P2093
Daniela Balzi
Emilia Antonucci
Marco Miranda
Niccolò Maggini
Rita Paniccia
Rosanna Abbate
P304
P356
10.1160/TH09-12-0832
P577
2010-05-10T00:00:00Z